IDXX

643.78

0.41% 2.64

Dopo l'orario di chiusura: 643.99 0.21 +0.03%

Idexx Laboratories Inc (IDXX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché IDXX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$641.14

Aprire:

$641.73

Volume 24 ore:

333.76K

Relative Volume:

0.61

Capitalizzazione di mercato:

$51.51B

Reddito:

$4.04B

Utile/perdita netta:

$985.66M

Rapporto P/E:

53.60

EPS:

12.01

Flusso di cassa netto:

$774.34M

1 W Prestazione:

-1.39%

1M Prestazione:

-1.08%

6M Prestazione:

+55.02%

1 anno Prestazione:

+28.61%

Intervallo 1D:

$641.73

$651.33

Intervallo di 1 settimana:

$625.55

$655.77

Portata 52W:

$356.14

$688.12

Idexx Laboratories Inc Stock (IDXX) Company Profile

Nome

Idexx Laboratories Inc

Settore

Healthcare (1155)

Industria

Diagnostics & Research (55)

Telefono

(207) 556-0300

Indirizzo

ONE IDEXX DRIVE, WESTBROOK, ME

Dipendente

11,000

Cinguettio

@idexx

Prossima data di guadagno

2025-02-03

Ultimi documenti SEC

IDXX's Discussions on Twitter

Confronta IDXX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IDXX Idexx Laboratories Inc	643.78	51.29B	4.04B	985.66M	774.34M	12.01
TMO Thermo Fisher Scientific Inc	474.57	181.05B	43.21B	6.58B	6.17B	17.29
DHR Danaher Corp	188.52	136.09B	24.01B	3.41B	4.86B	4.70
A Agilent Technologies Inc	125.62	34.94B	6.79B	1.22B	1.09B	4.26
IQV Iqvia Holdings Inc	186.06	31.83B	15.70B	1.24B	2.01B	6.91

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-05	Reiterato	BTIG Research	Buy
2025-07-01	Iniziato	Jefferies	Buy
2024-12-02	Iniziato	Leerink Partners	Outperform
2024-07-25	Iniziato	BTIG Research	Buy
2024-01-30	Downgrade	Piper Sandler	Overweight → Neutral
2023-12-07	Iniziato	Exane BNP Paribas	Outperform
2023-12-04	Aggiornamento	Cleveland Research	Neutral → Buy
2023-08-02	Downgrade	Atlantic Equities	Overweight → Neutral
2022-07-25	Downgrade	Stifel	Buy → Hold
2022-07-21	Aggiornamento	Goldman	Neutral → Buy
2022-07-12	Iniziato	Piper Sandler	Overweight
2022-05-05	Downgrade	BofA Securities	Buy → Neutral
2022-02-08	Iniziato	Atlantic Equities	Overweight
2021-11-18	Iniziato	Morgan Stanley	Overweight
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-07-12	Downgrade	Guggenheim	Buy → Neutral
2021-02-17	Iniziato	Barclays	Overweight
2019-09-09	Iniziato	Goldman	Neutral
2019-05-23	Iniziato	Guggenheim	Buy
2018-11-02	Reiterato	BofA/Merrill	Buy
2018-05-07	Reiterato	Stifel	Buy
2018-01-16	Iniziato	Piper Jaffray	Overweight
2017-08-23	Aggiornamento	BofA/Merrill	Neutral → Buy
2017-07-28	Aggiornamento	CL King	Neutral → Buy
2017-02-03	Downgrade	Feltl & Co.	Hold → Sell
2016-09-29	Ripresa	BofA/Merrill	Neutral
2016-08-16	Reiterato	Stifel	Buy
2016-08-03	Aggiornamento	Northcoast	Sell → Neutral
2016-07-20	Reiterato	Canaccord Genuity	Buy
2016-04-19	Reiterato	Canaccord Genuity	Buy
2016-04-01	Iniziato	CL King	Neutral
2016-03-21	Reiterato	Stifel	Buy
2016-02-04	Iniziato	Credit Suisse	Outperform
2015-10-29	Reiterato	Stifel	Buy
2015-08-28	Downgrade	Raymond James	Outperform → Mkt Perform
2015-08-13	Reiterato	Stifel	Buy
2015-07-23	Reiterato	Canaccord Genuity	Buy

Mostra tutto

Idexx Laboratories Inc Borsa (IDXX) Ultime notizie

04:19 AM

Peloton Wealth Strategists Raises Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

04:19 AM

Fred Alger Management LLC Grows Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat

04:19 AM

04:06 AM

AG2R LA Mondiale Gestion D Actifs Makes New $1.47 Million Investment in IDEXX Laboratories, Inc. $IDXX - MarketBeat

04:06 AM

03:28 AM

Glenview Trust co Acquires 17,761 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat

03:28 AM

03:01 AM

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Purchases 290,551 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat

03:01 AM

Sep 14, 2025